EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Artificial Intelligence for the Digital Revolution of Pharmaceutical Manufacturing
Currently Artificial Intelligence AIMachine Learning ML model development programs are scattered and difficult to use particularly for scientists with less experience in computer programming eg Python Different computer programs are needed to deploy different AIML methods
-
Techno Trends
Salanersen Receives FDA Breakthrough Status for Spinal Muscular Atrophy
Biogen has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to salanersen an investigational treatment for spinal muscular atrophy SMA
-
Projects
Siemens Invests $14 Million in Drummondville Plant Expansion to Advance Digital Manufacturing
Siemens Canada has completed a major expansion and modernisation project at its manufacturing facility in Drummondville Qubec The yearlong project represents an investment of approximately US million
-
Research Insights
Limited efficacy of a therapeutic anti-CD40 monoclonal antibody to inhibit activated CD4 T cell autoimmunity in vitro
Iscalimab is a nondepleting antiCD monoclonal antibody expected to suppress immune responses by blocking the costimulation by antigenpresenting cells through CDCDL ligation
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
How Regulatory Intelligence Drives Competitive Advantage in Pharma
Kate Williamson
Regulatory intelligence is now a strategic enabler of pharmaceutical business in the context of helping to make smarter decisions in the areas of drug development, regulatory submissions, and market a...
-
2
Machine Learning for Process Monitoring and Control of Hot-Melt Extrusion: Current State of the Art and Future Directions
Marion McAfee
Darren Whitaker
Michael Nugent
NimraMunir
In the last few decades, hot-melt extrusion (HME) has emerged as a rapidly growing technology in the pharmaceutical industry, due to its various advantages over other fabrication routes for drug deliv...
-
3
Mastering Pharma Innovation: EU's Triumph over Advanced Manufacturing Challenges
Kate Williamson
In the dynamic realm of pharmaceuticals, the European Union (EU) has excelled in overcoming advanced manufacturing hurdles, showcasing prowess in innovation and collaboration. This article explores th...
-
4
The Influence of Big Pharma on Healthcare Policies in America: Unraveling the Complex Web
Kate Williamson
This article explores the intricate relationship between Big Pharma and healthcare policies in the United States, unraveling the historical context, lobbying tactics, and policy impact. It delves into...
-
5
Navigating the Landscape of Pharmacogenomics in Diagnosis to Drug Delivery in Cancer Therapeutics
Vikas Jhawat
Monika Gulia
In the realm of cancer therapeutics, pharmacogenomics has emerged as a critical linchpin in shaping treatment decisions. The relentless adaptability of cancer cells, often culminating in resistance to...
press releasesRead more...
Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA®
Tonix Pharmaceuticals Holding Corp a fully integrated commercialstage biotechnology company today announced a major managed Medicare agreement for TONMYA cyclobenzaprine HCl sublingual tablets
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
Alamar Biosciences Inc Nasdaq ALMR a leader in precision proteomics dedicated to advancing the early detection of disease today announced a partnership with leading research universities to launch
A New Approach to Treating Brain Cancer: HDT Bio Launches Canadian Clinical Program at McGill University
Among the deadliest of brain cancers glioblastoma kills virtually everyone diagnosed and usually within months Decades of research have produced virtually no improvement No approved immunotherapy has ever demonstrated a survival benefit
BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies
BioMed X a leading innovation engine for pharma and Boehringer Ingelheim today announced the launch of a new research team at XSeed Labs the established innovation incubator embedded within Boehringers US RD headquarters
Events Read more...
16 - 19
Jul 2026Bio Asia Taiwan 2026
Taipei Nangang Exhibition Cent...
20 - 22
Jul 20266th mRNA-Based Therapeutics Summit
The Westin Boston Seaport Dist...
20 - 22
Jul 2026Liquid Biopsy for Precision Oncology Summit
Boston, MA, USA
24 - 25
Jul 2026Cardiovascular Medicine Pharmacology 2026
Paris, France
26 - 30
Jul 2026ADLM 2026
Anaheim, CA USA
27 - 28
Jul 2026Pharmacovigilance & Drug Safety 2026
Rome, Italy
27 - 28
Jul 2026Pharmacology 2026
Rome, Italy
27 - 28
Jul 2026PharmaSci Innovations 2026
Rome, Italy
LATEST NEWSRead more...
U.S. FDA Approves PADCEV Plus Keytruda for Perioperative Treatment of Muscle-Invasive Bladder Cancer
The US Food and Drug Administration FDA has approved PADCEV enfortumab vedotinejfv in combination with Keytruda pembrolizumab or Keytruda QLEX pembrolizumab and berahyaluronidase
U.S. FDA Approves Subcutaneous Sarclisa Escena as First Anticancer Therapy Delivered via On-Body Injector
The US Food and Drug Administration FDA has approved Sarclisa Escena isatuximabirfc for subcutaneous administration in combination with standard treatment regimens for patients with multiple myeloma
FDA Approves ENNUMO Pegfilgrastim Biosimilar for Accord BioPharma
Accord BioPharma has received US Food and Drug Administration FDA approval for ENNUMO pegfilgrastimpccg a biosimilar to NEULASTA pegfilgrastim The product is approved for the same indications as the reference medicine
Teva and Polpharma Biologics Sign Global Licensing Agreement for Ocrelizumab Biosimilar Candidate
Teva Pharmaceuticals International and Polpharma Biologics International have entered into a global licensing agreement under which Teva will receive exclusive rights to commercialise both the intravenous and subcutaneous formulations
Catalent and Nanoscope Therapeutics Expand Partnership for MCO-010 Development and Commercial Supply
Catalent and Nanoscope Therapeutics have expanded their partnership to support the latestage clinical development and future commercial supply of MCO Nanoscopes lead optogenetic gene therapy for retinal degenerative diseases
Certara Partners with NVIDIA to Advance AI-Driven Drug Discovery and Development
Certara has partnered with NVIDIA to enhance its open integrated artificial intelligence AI platform bringing together its scientific software regulatory expertise and proprietary datasets with AIfirst agentbased technologies to support drug discovery and development
